Sterling Biotech Financials
NSE: STERLINBIO | BSE: 512299
₹0.70
₹0.00 (0.00%)As on 05-Nov-2018IST
Market cap
₹21 Cr
Revenue (TTM)
₹457 Cr
P/E Ratio
--
P/B Ratio
-0
Div. Yield
0 %
Income Statement (₹ Cr) |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
456.85
|
434.25
|
409.88
|
352.33
|
368.43
|
523.99
|
|||||
|
Total Income
|
476.71
|
444.31
|
414.35
|
357.83
|
372.40
|
531.84
|
|||||
|
Total Expenditure
|
390.66
|
375.49
|
459.37
|
338.24
|
355.85
|
459.53
|
|||||
|
EBITDA
|
66.19
|
58.77
|
-49.48
|
14.10
|
12.57
|
64.46
|
|||||
|
Depreciation
|
15.27
|
158.18
|
242.84
|
245.75
|
263.55
|
345.14
|
|||||
|
EBIT
|
50.92
|
-99.41
|
-292.32
|
-231.65
|
-250.97
|
-280.69
|
|||||
|
Interest
|
0.72
|
0.24
|
2.06
|
439.67
|
369.80
|
414.78
|
|||||
|
Other Income
|
19.86
|
10.05
|
4.46
|
5.50
|
3.98
|
7.85
|
|||||
|
Exceptional Items
|
-76.99
|
6,321.37
|
--
|
-772.29
|
--
|
--
|
|||||
|
Profit before Tax
|
-6.93
|
6,231.78
|
-289.92
|
-1,438.12
|
-616.80
|
-687.62
|
|||||
|
Provision for Tax
|
12.35
|
243.07
|
5.31
|
-432.73
|
-204.34
|
-237.15
|
|||||
|
Profit after Tax
|
-19.29
|
5,988.71
|
-295.23
|
-1,005.39
|
-412.46
|
-450.47
|
Liabilities (₹ Cr) |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
879.42
|
898.67
|
-5,732.54
|
275.85
|
1,276.09
|
1,663.74
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
-294.90
|
-307.97
|
6,276.71
|
1,165.88
|
3,611.94
|
3,986.00
|
|||||
|
Current Liabilities
|
52.01
|
29.25
|
1,340.07
|
5,622.56
|
3,087.48
|
2,530.41
|
|||||
|
Total Liabilities
|
936.33
|
932.08
|
2,432.34
|
7,877.15
|
8,355.09
|
8,360.22
|
Assets (₹ Cr) |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
235.05
|
299.15
|
1,535.19
|
6,583.63
|
6,892.09
|
7,129.12
|
|||||
|
Current Assets
|
401.48
|
320.80
|
351.20
|
480.66
|
1,083.42
|
1,051.03
|
|||||
|
Total Assets
|
936.33
|
932.08
|
2,432.34
|
7,877.15
|
8,355.09
|
8,360.22
|
|||||
|
Total Debt*
|
10.82
|
--
|
8,064.66
|
7,492.69
|
6,949.01
|
6,567.54
|
|||||
|
Net Current Assets
|
349.47
|
291.55
|
-988.87
|
-5,141.89
|
-2,004.07
|
-1,479.38
|
|||||
|
Contingent Liabilities
|
--
|
--
|
10,147.86
|
383.73
|
105.74
|
100.51
|
Cashflow (₹ Cr) |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
48.84
|
-15.69
|
32.39
|
-32.81
|
0.95
|
67.03
|
|||||
|
Cash Flow from Investing Activities
|
-98.28
|
-119.22
|
1.15
|
-9.15
|
-49.28
|
-84.45
|
|||||
|
Cash from Financing Activities
|
9.86
|
4.56
|
54.84
|
38.44
|
48.62
|
16.40
|
|||||
|
Net Cash Inflow / Outflow
|
-39.58
|
-130.35
|
88.38
|
-3.52
|
0.29
|
-1.02
|
Financials Ratios |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-0.03
|
9.31
|
-10.85
|
-36.94
|
-15.15
|
-16.55
|
|||||
|
Cash EPS (₹)
|
-0.01
|
9.55
|
-1.93
|
-27.91
|
-5.47
|
-3.87
|
|||||
|
Adjusted Book Value (₹)
|
1.37
|
1.40
|
-210.62
|
10.14
|
46.89
|
61.13
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
0.08
|
-0.02
|
1.19
|
-1.21
|
0.03
|
2.46
|
|||||
|
Free Cash Flow per Share (₹)
|
-0.10
|
9.43
|
-2.15
|
-30.11
|
-7.85
|
-6.92
|
Profitability Ratios |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
-0.70
|
385.79
|
-5.70
|
-12.49
|
-3.00
|
-3.55
|
|||||
|
ROE (%)
|
-2.17
|
--
|
--
|
-129.56
|
-28.06
|
-33.35
|
|||||
|
ROA (%)
|
-3.07
|
477.82
|
-6.60
|
-13.37
|
-5.11
|
-5.95
|
|||||
|
EBIT Margin (%)
|
11.14
|
-22.89
|
-71.32
|
-65.75
|
-68.12
|
-53.57
|
|||||
|
Net Margin (%)
|
-4.05
|
1,347.88
|
-71.25
|
-280.96
|
-110.76
|
-84.70
|
|||||
|
Cash Profit Margin (%)
|
-0.88
|
1,415.51
|
-12.78
|
-211.17
|
-37.21
|
-18.79
|
Growth Ratios |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
5.20
|
5.95
|
16.33
|
-4.37
|
-29.69
|
-21.43
|
|||||
|
EBIT Growth (%)
|
151.22
|
65.99
|
--
|
7.70
|
10.59
|
--
|
|||||
|
Net Profit Growth (%)
|
-100.32
|
2,128.49
|
70.64
|
-143.76
|
8.44
|
1.58
|
|||||
|
EPS Growth (%)
|
-100.32
|
185.82
|
70.64
|
-143.76
|
8.44
|
1.62
|
|||||
|
Book Value Growth (%)
|
-2.14
|
115.68
|
-2,178.11
|
-78.38
|
-23.30
|
60.37
|
Valuation Ratios |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
--
|
--
|
0.16
|
0.09
|
0.06
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
5.25
|
6.95
|
-175.33
|
383.95
|
425.92
|
92.09
|
|||||
|
Close Price (₹)
|
--
|
--
|
--
|
1.75
|
4.30
|
4.00
|
|||||
|
High Price (₹)
|
--
|
--
|
--
|
6.80
|
5.25
|
8.65
|
|||||
|
Low Price (₹)
|
--
|
--
|
--
|
1.64
|
2.95
|
3.82
|
|||||
|
Market Cap (₹ Cr)
|
--
|
--
|
--
|
45.18
|
117.03
|
107.78
|
Solvency Ratios |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.01
|
--
|
-1.41
|
27.16
|
5.45
|
3.95
|
|||||
|
Short term debt to equity ratio
|
0.01
|
--
|
-0.22
|
4.39
|
0.75
|
0.56
|
|||||
|
Current Ratio
|
7.72
|
10.97
|
0.26
|
0.09
|
0.35
|
0.42
|
|||||
|
Quick Ratio
|
5.36
|
7.70
|
0.19
|
0.07
|
0.12
|
0.13
|
|||||
|
Interest Coverage
|
-8.68
|
--
|
-139.69
|
-2.27
|
-0.67
|
-0.66
|
Operating Efficiency Ratios |
Mar-24 | Mar-23 | Mar-22 | Mar-18 | Mar-17 | Mar-16 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | Dec-10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.53
|
11.51
|
8.76
|
14.57
|
11.76
|
8.06
|
|||||
|
Asset Turnover
|
0.73
|
0.35
|
0.09
|
0.05
|
0.05
|
0.07
|
|||||
|
Receivable days
|
41.01
|
36.09
|
38.84
|
48.03
|
39.03
|
72.54
|
|||||
|
Inventory Days
|
87.13
|
79.02
|
68.28
|
387.72
|
647.95
|
440.22
|
|||||
|
Payable days
|
58.31
|
46.71
|
42.79
|
42.52
|
40.20
|
24.21
|
|||||
|
Cash Conversion Cycle
|
69.82
|
68.41
|
64.34
|
393.22
|
646.78
|
488.55
|